Loyola testing new procedure to relieve pain of cancer that has spread to spine

News Archive December 30, 2014

Loyola testing new procedure to relieve pain of cancer that has spread to spine

MAYWOOD, Ill. (December 30, 2014) – When metastatic cancer spreads to the spine, it can cause spinal fractures, severe pain and impaired mobility. Loyola University Medical Center has launched the first clinical trial in the United States of a minimally invasive treatment designed to help relieve pain, heal spinal fractures and prevent new fractures.

In metastatic cancer, the most common site the cancer spreads to are the bones, and the spine is the most common site of bone metastases. A tumor can weaken a vertebra, causing it to collapse on itself.

Loyola will test a new combination treatment that delivers radiation directly to the tumor and increases support of the spine.

First, an interventional radiologist makes a small incision into the spine and inserts a spinal applicator needle to deliver radiation directly to the tumor. This is called intraoperative radiotherapy. Because it is more precise than standard external beam radiation, intraoperative radiotherapy can deliver a higher dose of radiation, while minimizing adverse effects to normal tissue.

The second half of the operation is a procedure called a kyphoplasty. A catheter is inserted through the incision. A balloon at the tip of the catheter is inflated to increase the height of the collapsed vertebra and a cementlike material then is injected into the radiated area to help stabilize the spine.

The purpose of the Phase 1 study is to learn about both the good and bad effects of combining intraoperative radiotherapy and kyphoplasty. Researchers will compare the pain levels and use of pain medications before and after the procedure. They also will monitor quality-of-life issues, the effect of the procedure on the tumor and any complications.

The study is titled “Combining Intraoperative Radiotherapy with Kyphoplasty for Treatment of Spinal Metastases (Kypho-IORT )”. It is sponsored by the departments of Radiation Oncology and Radiology of Loyola University Chicago Stritch School of Medicine.

The principal investigator is William Small Jr., MD, chair of the Department of Radiation Oncology. Co-investigators are Angelo Malamis, MD; Abhishek Solanki, MD; Karan Shah, MD; and Janushi Dalal, MD.

To qualify for the trial, a patient must meet several criteria, including being 50 or older and having metastatic cancer that has spread from a solid tumor to the spine. For more information, call 708-216-2568.

]]>
The Loyola University Chicago Health Sciences Division (HSD) advances interprofessional, multidisciplinary, and transformative education and research while promoting service to others through stewardship of scientific knowledge and preparation of tomorrow's leaders. The HSD is located on the Health Sciences Campus in Maywood, Illinois. It includes the Marcella Niehoff School of Nursing, the Stritch School of Medicine, the biomedical research programs of the Graduate School, and several other institutes and centers encouraging new research and interprofessional education opportunities across all of Loyola University Chicago. The faculty and staff of the HSD bring a wealth of knowledge, experience, and a strong commitment to seeing that Loyola's health sciences continue to excel and exceed the standard for academic and research excellence. For more on the HSD, visit LUC.edu/hsd.
© 2011 Loyola University Chicago Health Sciences Division. All rights reserved.  &npsp; Privacy Policy   Privacy Policy